Skip to main content
SpringerLink
Log in

Closing Remarks

  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Bonneterre J, Chevallier B, Metz R, et al. A randomized doubleblind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil and doxorubicin or epirubicin chemotherapy. Journal of Clinical Oncology 8: 1063–1069, 1990

    PubMed  CAS  Google Scholar 

  • Chevallier B. Efficacy and safety of granisetron compared with high-dose metoclopramide plus dexamethasone in patients receiving high-dose cisplatin in a single-blind study. European Journal of Cancer 26: 533–536, 1990

    Google Scholar 

  • Coates A, Abraham S, Kaye SB, et al. On the receiving end — patient perception of the side effects of cancer chemotherapy. Clinics in Oncology 19: 203–208, 1983

    CAS  Google Scholar 

  • Cunningham D, Turner A, Hawthorne J, et al. Ondansetron with and without dexamethasone to treat chemotherapy-induced emesis. Lancet 1: 1323, 1990

    Google Scholar 

  • Hamik A, Peroutka SJ. Differential interactions of traditional and novel antiemetics with dopamine D2 and 5-hydroxytryptamine3 receptors. Cancer Chemotherapy and Pharmacology 24: 307–310, 1990

    Article  Google Scholar 

  • Hesketh PJ, Gandara DR. Serotonin antagonists: a new class of antiemetic agents. Journal of the National Cancer Institute 83: 613–620, 1991

    Article  PubMed  CAS  Google Scholar 

  • Marty M, Poillart P, Scholl S, et al. Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (CR38032 F) with high-dose metoclopramide in the control of cisplatin-induced emesis. New England Journal of Medicine 322: 816–821, 1990

    Article  PubMed  CAS  Google Scholar 

  • Miner WD, Sanger GJ. Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine m-receptor antagonism. British Journal of Pharmacology 88: 497–499, 1986

    Article  PubMed  CAS  Google Scholar 

  • Roila F, Tonato M, Cognetti F, et al. Prevention of cisplatin-induced emesis: a double blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone. Journal of Clinical Oncology 9: 675–678, 1991

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Medical Oncology, University of Naples Medical School II, via S. Pansini 5, 80131, Naples, Italy

    A. Raffaele Bianco

Authors
  1. A. Raffaele Bianco
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bianco, A.R. Closing Remarks. Drugs 43 (Suppl 3), 43–44 (1992). https://doi.org/10.2165/00003495-199200433-00010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199200433-00010

Keywords

Search

Navigation